M&A Deal Summary |
|
|---|---|
| Date | 2018-12-10 |
| Target | Spatial Transcriptomics |
| Sector | Life Science |
| Buyer(s) | 10X Genomics |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2012 |
| Sector | Life Science |
| Employees | 1,306 |
| Revenue | 611M USD (2024) |
10X Genomics provides a genomics platform that upgrades the capabilities of existing short read sequencers. The Company does this through a combination of elegant microfluidics, chemistry, and bioinformatics. With the GemCode Platform, researchers can now find structural variants, haplotypes, and other valuable long range information while leveraging existing sequencing workflows. 10X Genomics was founded in 2012 and is based in Pleasanton, California.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Life Science M&A | 2 of 3 |
| Type: Add-on Acquisition M&A Deals | 2 of 3 |
| Country: Sweden M&A | 1 of 1 |
| Year: 2018 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-08-28 |
Epinomics
Menlo Park, California, United States Epinomics Inc. is a revolutionizing personalized medicine through scientific research, deep analytics, and clinical application development. Epinomics, Inc. was founded in 2013 and is based in Menlo Park, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-08-07 |
Scale Biosciences
San Diego, California, United States Scale Biosciences is a biotechnology company specializing in scalable single-cell analysis technologies. Scale Biosciences includes instrument-free barcoding kits for RNA and methylation profiling, enabling high-throughput, cost-efficient single-cell experiments. Scale Biosciences is based in San Diego, California. |
Buy | - |
